Quantum Rare Earth Developments Welcomes Former Molycorp CEO To Its Advisory Board; Announces Name Change
Radiopharm Theranostics and Cyclotek Sign Clinical Supply Agreement for ¹?¹Tb-KLK3-mAb Phase I Clinical Trial in Australia